5899 related articles for article (PubMed ID: 2828247)
1. JB/MS murine melanoma: a new model for studies on the modulation of differentiation and of tumorigenic and metastatic potential.
Hearing VJ; Cannon GB; Vieira WD; Jiménez-Atiénzar M; Kameyama K; Law LW
Int J Cancer; 1988 Feb; 41(2):275-82. PubMed ID: 2828247
[TBL] [Abstract][Full Text] [Related]
2. Differentiation and the tumorigenic and metastatic phenotype of murine melanoma cells.
Kameyama K; Vieira WD; Tsukamoto K; Law LW; Hearing VJ
Int J Cancer; 1990 Jun; 45(6):1151-8. PubMed ID: 2161802
[TBL] [Abstract][Full Text] [Related]
3. Phenotypic instability of mouse melanomas after propagation in vivo and in vitro.
Berkelhammer J; Luethans TN; Hook RR; Oxenhandler RW
Cancer Res; 1986 Jun; 46(6):2923-8. PubMed ID: 3698017
[TBL] [Abstract][Full Text] [Related]
4. Development of a new melanoma model in C57BL/6 mice.
Berkelhammer J; Oxenhandler RW; Hook RR; Hennessy JM
Cancer Res; 1982 Aug; 42(8):3157-63. PubMed ID: 7093959
[TBL] [Abstract][Full Text] [Related]
5. Alpha-melanocyte stimulating hormone-induced pigmentation is blocked by depletion of protein kinase C.
Park HY; Russakovsky V; Ao Y; Fernandez E; Gilchrest BA
Exp Cell Res; 1996 Aug; 227(1):70-9. PubMed ID: 8806453
[TBL] [Abstract][Full Text] [Related]
6. Transcriptional induction of the melanocyte-stimulating hormone receptor in brain metastases of murine K-1735 melanoma.
Radinsky R; Beltran PJ; Tsan R; Zhang R; Cone RD; Fidler IJ
Cancer Res; 1995 Jan; 55(1):141-8. PubMed ID: 7805024
[TBL] [Abstract][Full Text] [Related]
7. Murine melanoma-specific tumor rejection activity elicited by a purified, melanoma-associated antigen.
Hearing VJ; Gersten DM; Montague PM; Vieira WD; Galetto G; Law LW
J Immunol; 1986 Jul; 137(1):379-84. PubMed ID: 3711669
[TBL] [Abstract][Full Text] [Related]
8. Demonstration of B700 cross-reactive antigens on human and other animal melanomas.
Gersten DM; Hearing VJ
Pigment Cell Res; 1988; 1(6):434-8. PubMed ID: 3237611
[TBL] [Abstract][Full Text] [Related]
9. Malignant melanoma: cross-reacting (common) tumor rejection antigens.
Hearing VJ; Vieira WD; Law LW
Int J Cancer; 1985 Mar; 35(3):403-9. PubMed ID: 2579039
[TBL] [Abstract][Full Text] [Related]
10. Expression of melanocyte stimulating hormone receptors correlates with mammalian pigmentation, and can be modulated by interferons.
Kameyama K; Montague PM; Hearing VJ
J Cell Physiol; 1988 Oct; 137(1):35-44. PubMed ID: 2459141
[TBL] [Abstract][Full Text] [Related]
11. A unique tumor rejection antigen from the S91 murine malignant melanoma.
Law LW; Vieira WD; Kameyama K; Hearing VJ
Cancer Res; 1987 Nov; 47(22):5841-5. PubMed ID: 3664485
[TBL] [Abstract][Full Text] [Related]
12. Control of melanogenesis in mouse melanoma cells of varying metastatic potential.
Niles RM; Makarski JS
J Natl Cancer Inst; 1978 Aug; 61(2):523-6. PubMed ID: 210294
[TBL] [Abstract][Full Text] [Related]
13. Alpha-melanocyte-stimulating hormone blocks invasion of reconstituted basement membrane (Matrigel) by murine B16 melanoma cells.
Murata J; Ayukawa K; Ogasawara M; Fujii H; Saiki I
Invasion Metastasis; 1997; 17(2):82-93. PubMed ID: 9561027
[TBL] [Abstract][Full Text] [Related]
14. Anchorage-independent growth of murine melanoma in serum-less media is dependent on insulin or melanocyte-stimulating hormone.
Bregman MD; Abdel Malek ZA; Meyskens FL
Exp Cell Res; 1985 Apr; 157(2):419-28. PubMed ID: 3920061
[TBL] [Abstract][Full Text] [Related]
15. Poorly metastatic tumor cell variants as primary targets of syngeneic antibody responses against murine melanoma.
Parratto NP; Odebralski JM; Kimura AK
Cancer Res; 1989 Jul; 49(14):3722-8. PubMed ID: 2736512
[TBL] [Abstract][Full Text] [Related]
16. Induction of melanoma in TPras transgenic mice.
Broome Powell M; Gause PR; Hyman P; Gregus J; Lluria-Prevatt M; Nagle R; Bowden GT
Carcinogenesis; 1999 Sep; 20(9):1747-53. PubMed ID: 10469620
[TBL] [Abstract][Full Text] [Related]
17. Increased experimental metastatic capacity of a murine melanoma following induction of differentiation.
Bennett DC; Dexter TJ; Ormerod EJ; Hart IR
Cancer Res; 1986 Jul; 46(7):3239-44. PubMed ID: 3708559
[TBL] [Abstract][Full Text] [Related]
18. The relationship between susceptibility to retinoic acid treatment and protein kinase C alpha expression in murine melanoma cell lines.
Niles RM; Combs R
Exp Cell Res; 1996 Feb; 223(1):20-8. PubMed ID: 8635492
[TBL] [Abstract][Full Text] [Related]
19. Effects of latanoprost on tyrosinase activity and mitotic index of cultured melanoma lines.
Dutkiewicz R; Albert DM; Levin LA
Exp Eye Res; 2000 May; 70(5):563-9. PubMed ID: 10870514
[TBL] [Abstract][Full Text] [Related]
20. Ecotropic C-type retrovirus of B16 melanoma and malignant transformation of normal melanocytes.
Li M; Xu F; Muller J; Hearing VJ; Gorelik E
Int J Cancer; 1998 May; 76(3):430-6. PubMed ID: 9579583
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
